Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10931040rdf:typepubmed:Citationlld:pubmed
pubmed-article:10931040lifeskim:mentionsumls-concept:C0023890lld:lifeskim
pubmed-article:10931040lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:10931040lifeskim:mentionsumls-concept:C1293122lld:lifeskim
pubmed-article:10931040lifeskim:mentionsumls-concept:C0806140lld:lifeskim
pubmed-article:10931040pubmed:issue8lld:pubmed
pubmed-article:10931040pubmed:dateCreated2000-9-6lld:pubmed
pubmed-article:10931040pubmed:abstractTextPortal hypertension due to chronic liver disease is a major cause of death worldwide. Orthotopic liver transplantation offers the best therapeutic option but is available to only a minority of patients. In the past few years mechanically pumping portal venous inflow has been reported to reduce portal hypertension and improve liver function.lld:pubmed
pubmed-article:10931040pubmed:languageenglld:pubmed
pubmed-article:10931040pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10931040pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10931040pubmed:statusMEDLINElld:pubmed
pubmed-article:10931040pubmed:monthAuglld:pubmed
pubmed-article:10931040pubmed:issn0007-1323lld:pubmed
pubmed-article:10931040pubmed:authorpubmed-author:MathieR TRTlld:pubmed
pubmed-article:10931040pubmed:authorpubmed-author:SeifalianA...lld:pubmed
pubmed-article:10931040pubmed:authorpubmed-author:DavidsonB RBRlld:pubmed
pubmed-article:10931040pubmed:authorpubmed-author:HabibNNlld:pubmed
pubmed-article:10931040pubmed:authorpubmed-author:JianL SLSlld:pubmed
pubmed-article:10931040pubmed:issnTypePrintlld:pubmed
pubmed-article:10931040pubmed:volume87lld:pubmed
pubmed-article:10931040pubmed:ownerNLMlld:pubmed
pubmed-article:10931040pubmed:authorsCompleteYlld:pubmed
pubmed-article:10931040pubmed:pagination984-91lld:pubmed
pubmed-article:10931040pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:meshHeadingpubmed-meshheading:10931040...lld:pubmed
pubmed-article:10931040pubmed:year2000lld:pubmed
pubmed-article:10931040pubmed:articleTitlePortal flow augmentation for liver cirrhosis.lld:pubmed
pubmed-article:10931040pubmed:affiliationLiver Surgery Unit, Imperial College School of Medicine, Hammersmith Hospital and University Department of Surgery, Royal Free and University College Medical School, University College London, London, UK.lld:pubmed
pubmed-article:10931040pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10931040pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10931040pubmed:publicationTypeMeta-Analysislld:pubmed